Extended-spectrum β-lactamases in Enterobacter cloacae:: underestimated but clinically significant!

被引：13

作者：

Crowley, B ^{[1
]}

Ratcliffe, G ^{[1
]}

机构：

[1] Univ Hosp Aintree, Liverpool Publ Hlth Lab, Liverpool L9 7AL, Merseyside, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2003年 / 51卷 / 05期

关键词：

ESBLs; Enterobacter cloacae;

D O I：

10.1093/jac/dkg206

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：1316 / 1317

页数：2

相关论文

共 6 条

[1] [Anonymous], M100S10 NCCLS
[2] Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat
Bradford, PA
[J]. CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) : 933 - 951
[3] Detection of β-lactamase-mediated resistance
Livermore, DM
Brown, DFJ
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 : 59 - 64
[4] β-lactamases:: which ones are clinically important?
Rice, LB
Bonomo, RA
[J]. DRUG RESISTANCE UPDATES, 2000, 3 (03) : 178 - 189
[5] Sirot J, 1996, CLIN MICROBIOL INFEC, V2, pS35
[6] Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital
Vercauteren, E
Descheemaeker, P
Ieven, M
Sanders, CC
Goossens, H
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (09) : 2191 - 2197